The global somatostatin market is projected to grow from $290.3 million in 2021 to $498.1 million in 2026, with a CAGR of 11.4% during this period. The analysis covers market segmentation by type and application, significant regional markets, and key participating companies such as Merck and Sanofi-Aventis. This report aims to identify growth areas, trends, and the competitive landscape of the somatostatin market.